Gemini Unlocks Free Personalized AI Image Gen for US Users, DeepSeek Slashes Token Prices 75% Permanently | AI Daily Brief
Audio in Mandarin Chinese · English transcript below
⚡ Free image gen hardware drops, bio-AI infra heats up, LLM price wars fuel edge AI, prompt fails reshape social
AI is accelerating its deep penetration into personal and sensitive domains. Google's Gemini has opened personalized image generation based on user ecosystem data, while NVIDIA has transformed biomolecular models into agent capabilities through BioNeMo—marking a new stage in technical capabilities for mining personal profiles and life data. Notably, U.S. lawmakers pushed forward legislation on the same day to prohibit AI companies from selling health data. This collision between expansion and defensive lines foreshadows that the AI industry is entering an era of stricter data compliance.
Today's Top 3 Headlines
- AI Industry News
🤖 Google Gemini Personalized AI Image Generation Now Free for US Users
Google opens Gemini's personalized AI image generation to all free U.S. users, previously paywalled. Users get auto-generated custom illustrations from their account data—zero prompt engineering needed, a major convenience leap.
Source ↗ - Others
🤖 AI Bill Shock: Enterprise Boycott, DeepSeek Cuts Token Prices 75% Permanently
Industry sources say multiple firms are collectively resisting soaring model costs amid staggering AI bills, while DeepSeek has permanently slashed token prices by 75%. For developers and enterprises, this means LLM usage costs are being dramatically compressed and the price barrier for large-scale AI application deployment is rapidly crumbling.
Source ↗ - Technology
🤖 Nvidia launches BioNeMo Agent Toolkit, turning biomolecular models into AI Agent skills to accelerate drug discovery
Nvidia launched BioNeMo Agent Toolkit, turning biomolecular models into skills directly callable by Agents to accelerate drug discovery. For R&D teams, this means AI can autonomously invoke molecular simulation capabilities, lowering bio-compute barriers and shortening drug development cycles.
Source ↗
+5 more headlines
- 🤖 Odyssey raises $310M as VCs double down on physical AI infrastructure
- 🤖 Prompt Engineering Is Quietly Failing: Prompt Regression Is the Root Cause
- 🤖 NLP Reshapes Professional Social Networks: AI-Powered Communication Gets Personalized Upgrade
- 🤖 Gemma 4 debuts: frontier AI hits edge devices first time
- 🤖 OpenAI teases new hardware device for Codex, launching July 15